InMode (NASDAQ:INMD – Get Free Report) announced its earnings results on Wednesday. The healthcare company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.05, FiscalAI reports. The firm had revenue of $92.14 million for the quarter, compared to analysts’ expectations of $91.58 million. InMode had a net margin of 20.69% and a return on equity of 11.99%. The company’s quarterly revenue was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.38 EPS.
InMode Price Performance
Shares of NASDAQ:INMD traded up $0.23 during trading on Wednesday, hitting $13.50. 420,340 shares of the company’s stock were exchanged, compared to its average volume of 785,534. The business’s 50-day simple moving average is $14.19 and its 200 day simple moving average is $14.31. The company has a market cap of $776.21 million, a price-to-earnings ratio of 10.98 and a beta of 1.98. InMode has a 52-week low of $12.72 and a 52-week high of $16.67.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut shares of InMode from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, November 2nd. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, InMode presently has a consensus rating of “Hold” and an average target price of $16.00.
Check Out Our Latest Stock Analysis on INMD
About InMode
InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications. The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments.
See Also
- Five stocks we like better than InMode
- Can Constellation Energy’s Contracts Power a Stock Rebound?
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
